AstraZeneca T\u00fcrkiye ve Roche Diagnostik T\u00fcrkiye’nin ko\u015fulsuz deste\u011fiyle d\u00fczenlenen etkinlikte, TKD Kalp Yetersizli\u011fi \u00c7al\u0131\u015fma Grubu Ba\u015fkan\u0131 Prof. Dr. Ahmet \u00c7elik ve T\u00fcrk Kardiyoloji Derne\u011fi Gelecek Ba\u015fkan\u0131 Prof. Dr. Muzaffer De\u011fertekin hastal\u0131kla ilgili de\u011ferlendirmelerde bulundu.<\/p>\n
Prof. Dr. \u00c7elik, kalp yetersizli\u011finin farmakolojik tedavisi konusunda 20’nci y\u00fczy\u0131ldan itibaren \u00f6nemli geli\u015fmeler kaydedildi\u011fini, modern ila\u00e7 tedavilerine s\u00fcrekli yenilerinin eklenmeye ba\u015fland\u0131\u011f\u0131n\u0131 s\u00f6yledi.<\/p>\n
![\"\"](\"https:\/\/www.aa.com.tr\/uploads\/userFiles\/96f91bbd-282f-4a24-a12c-1b1092cfeb3b\/009_2023%2F08_2023%2F27_Mayis%2F5%2F20230505_2_58537622_88647693.jpg\"\/)
<\/p>\n
\u00c7elik, “\u0130la\u00e7 tedavilerinin yan\u0131 s\u0131ra cihaz ve cerrahi tedavi se\u00e7enekleri konusunda da bulu\u015flar h\u0131zlanm\u0131\u015f, kalp destek cihazlar\u0131 1966’dan itibaren ileri evre kalp yetersizli\u011fi hastalar\u0131na tak\u0131lmaya ba\u015flanm\u0131\u015ft\u0131r. Kalp nakilleri ise 1967’den beri \u00fclkemiz dahil bir\u00e7ok \u00fclkede yap\u0131lmaktad\u0131r.” diye konu\u015ftu.<\/p>\n
“T\u00fcrkiye’de kalp yetersizli\u011fine yakalanma ya\u015f\u0131 daha gen\u00e7”<\/h3>\n
T\u00fcrkiye’de kalp rahats\u0131zl\u0131\u011f\u0131 g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131na ili\u015fkin olarak \u00c7elik, “T\u00fcrkiye’deki kalp yetersizli\u011fi g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131 bat\u0131l\u0131 \u00fclkelerin \u00e7o\u011fu ile benzer olmakla birlikte ortalama kalp yetersizli\u011fine yakalanma ya\u015f\u0131 daha gen\u00e7tir. T\u00fcrkiye’de bat\u0131 \u00fclkelerinden farkl\u0131 olarak kad\u0131nlarda kalp yetersizli\u011fi g\u00f6r\u00fclme oran\u0131 erkeklerden biraz daha y\u00fcksektir. \u00c7ocukluk \u00e7a\u011f\u0131ndan itibaren her ya\u015fta g\u00f6r\u00fclmekle birlikte \u00fclkemizde en s\u0131k g\u00f6r\u00fcld\u00fc\u011f\u00fc ya\u015f grubu 70 ya\u015f \u00fczeri pop\u00fclasyondur.” bilgisini verdi.<\/p>\n
![\"\"](\"https:\/\/www.aa.com.tr\/uploads\/userFiles\/96f91bbd-282f-4a24-a12c-1b1092cfeb3b\/009_2023%2F08_2023%2F27_Mayis%2F5%2F20230505_2_58537622_88647697.jpg\"\/)
<\/p>\n
Prof. Dr. \u00c7elik, kalp yetersizli\u011fi olan hastalarda bir\u00e7ok ba\u015fka hastal\u0131\u011f\u0131n da e\u015flik edebilece\u011fini vurgulayarak, T\u00fcrkiye’de kalp yetersizli\u011fi hastalar\u0131nda en s\u0131k birlikte g\u00f6r\u00fclen hastal\u0131klar\u0131, hipertansiyon, kalp damar hastal\u0131klar\u0131, dislipidemi, anksiyete, diyabet, KOAH (kronik obstr\u00fcktif akci\u011fer hastal\u0131\u011f\u0131), anemi, atriyal fibrilasyon, demir eksikli\u011fi, depresyon, hipotiroidizm ve kronik b\u00f6brek yetersizli\u011fi olarak s\u0131ralad\u0131.<\/p>\n
Kalp yetersizli\u011finin belirtileri ve tedavi y\u00f6ntemleri<\/h3>\n
Kalp yetersizli\u011finin ba\u015fl\u0131ca belirtilerine ve tedavi y\u00f6netmelerine de de\u011finen \u00c7elik, nefes darl\u0131\u011f\u0131, v\u00fccutta \u015fi\u015flik, halsizlik ve efor kapasitesinde azalmalar\u0131n hastal\u0131\u011f\u0131n belirtileri olabilece\u011fini anlatt\u0131.<\/p>\n
![\"\"](\"https:\/\/www.aa.com.tr\/uploads\/userFiles\/96f91bbd-282f-4a24-a12c-1b1092cfeb3b\/009_2023%2F08_2023%2F27_Mayis%2F5%2F20230505_2_58537622_88647695.jpg\"\/)
<\/p>\n
Prof. Dr. \u00c7elik, kalp yetersizli\u011fine yol a\u00e7an nedenler aras\u0131nda koroner arter hastal\u0131\u011f\u0131, hipertansiyon, diyabet, kalp kapak\u00e7\u0131k hastal\u0131klar\u0131, enfeksiyonlar, genetik etkenler ve kalbe yan etkide bulunan ila\u00e7lara maruziyetin say\u0131labilece\u011fine vurgu yaparak, s\u00f6zlerini \u015f\u00f6yle s\u00fcrd\u00fcrd\u00fc:<\/p>\n
“Kalp yetersizli\u011fi olan hastalar i\u00e7in bir\u00e7ok tedavi se\u00e7ene\u011fi bulunmaktad\u0131r. Geldi\u011fimiz noktada kalp yetersizli\u011fi olan hastan\u0131n durumunun ciddiyetine g\u00f6re ila\u00e7 tedavisinden kalp destek cihazlar\u0131na ve nakile kadar bir\u00e7ok imkandan faydalanabiliyoruz. Kalp yetersizli\u011finden dolay\u0131 artm\u0131\u015f olan \u00f6l\u00fcm riskini azaltan, hastal\u0131\u011f\u0131n k\u00f6t\u00fc ve olumsuz olan seyrini yava\u015flatabilen, bazen de iyi y\u00f6nde de\u011fi\u015ftirebilen bir\u00e7ok ila\u00e7 tedavisinin yan\u0131 s\u0131ra kalp yetersizli\u011finde ani \u00f6l\u00fcmlere neden olan ritim bozukluklar\u0131n\u0131 \u015fok verip d\u00fczelten ve kalbin yeniden senkronize bir \u015fekilde \u00e7al\u0131\u015fmas\u0131n\u0131 sa\u011flayan kalp pilleri mevcuttur. A\u011f\u0131rla\u015fm\u0131\u015f ve ileri kalp yetersizli\u011fi olan insanlarda da kalp destek cihazlar\u0131, yapay kalp ve kalp nakli devreye girmektedir. \u00dclkemizde bu tedavilerin hemen hepsi yap\u0131labilmektedir.”<\/p>\n
![\"\"](\"https:\/\/www.aa.com.tr\/uploads\/userFiles\/96f91bbd-282f-4a24-a12c-1b1092cfeb3b\/009_2023%2F08_2023%2F27_Mayis%2F5%2F20230505_2_58537622_88647703.jpg\"\/)
<\/p>\n
Kalp yetersizli\u011fini tedavi edebilmekten daha da de\u011ferli olan\u0131n hastal\u0131\u011f\u0131n hen\u00fcz ba\u015flamadan \u00f6nlemini alabilmek oldu\u011funa i\u015faret eden \u00c7elik, “Kalp yetersizli\u011fi ile s\u0131k g\u00f6r\u00fclen hastal\u0131klar\u0131 ve kalp yetersizli\u011fine neden olan muhtemel hastal\u0131klar\u0131 olan bireylerin bu hastal\u0131klar\u0131 ile ilgili etkin ve d\u00fczenli bir tedavi almalar\u0131 halinde kalp yetersizli\u011fine yakalanma olas\u0131l\u0131klar\u0131n\u0131n d\u00fc\u015fece\u011fi a\u015fikard\u0131r. Dolay\u0131s\u0131yla kalp yetersizli\u011fi ile m\u00fccadele ilk olarak kalp yetersizli\u011fi olmayan fakat diyabet, hipertansiyon, kalp damar hastal\u0131\u011f\u0131 gibi kalp yetersizli\u011fine yol a\u00e7an hastal\u0131klar\u0131 olan ki\u015fileri iyi tedavi etmekle ba\u015flamal\u0131d\u0131r. Kalp yetersizli\u011fi ile m\u00fccadelenin ana hedefi buraya kayd\u0131r\u0131lmal\u0131d\u0131r.” diye konu\u015ftu.<\/p>\n
“Bu hastal\u0131\u011fa yakalanmamak \u00e7ok \u00f6nemli”<\/h3>\n
Etkinlikle birlikte toplumda kalp yetersizli\u011fi konusundaki bilincin art\u0131r\u0131lmas\u0131n\u0131n hedeflendi\u011fini belirten \u00c7elik, hem toplumda hem de hekimlerde, sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131nda kalp yetersizli\u011fi fark\u0131ndal\u0131\u011f\u0131 olu\u015fturmak istediklerini, bu hastal\u0131\u011fa yakalanmaman\u0131n \u00e7ok \u00f6nemli oldu\u011funu, yakalan\u0131lmas\u0131 halinde de \u00e7ok tedavi se\u00e7ene\u011finin bulundu\u011funu kaydetti.<\/p>\n
![\"\"](\"https:\/\/www.aa.com.tr\/uploads\/userFiles\/96f91bbd-282f-4a24-a12c-1b1092cfeb3b\/009_2023%2F08_2023%2F27_Mayis%2F5%2F20230505_2_58537622_88647706.jpg\"\/)
<\/p>\n
\u00c7elik, hastal\u0131\u011f\u0131n \u00e7ocuklardan ya\u015fl\u0131lara her ya\u015f grubunda g\u00f6r\u00fclebildi\u011fine dikkati \u00e7ekerek, enfeksiyonlardan korunman\u0131n t\u00fcm ya\u015f gruplar\u0131 i\u00e7in \u00e7ok \u00f6nemli oldu\u011funu, bazen ciddi bir enfeksiyonun kalp yetersizli\u011fine sebep olabildi\u011fini vurgulad\u0131.<\/p>\n
“T\u00fcm d\u00fcnyada \u00e7\u0131\u011f gibi b\u00fcy\u00fcyen bir hastal\u0131k”<\/h3>\n
T\u00fcrk Kardiyoloji Derne\u011fi Gelecek Ba\u015fkan\u0131 Prof. Dr. Muzaffer De\u011fertekin de kalp yetersizli\u011finin hayat boyu tedavi gereksinimi, s\u0131k hastaneye yatma ihtiyac\u0131, \u00e7oklu ila\u00e7 tedavi gereksinimi, komplike ve pahal\u0131 cihaz tedavisi uygulamalar\u0131 nedeniyle hasta, hasta yak\u0131nlar\u0131, sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131 ve de sa\u011fl\u0131k ekonomisi \u00fczerine \u00e7ok b\u00fcy\u00fck y\u00fck getirdi\u011fini s\u00f6yledi.<\/p>\n
![\"\"](\"https:\/\/www.aa.com.tr\/uploads\/userFiles\/96f91bbd-282f-4a24-a12c-1b1092cfeb3b\/009_2023%2F08_2023%2F27_Mayis%2F5%2F20230505_2_58537622_88647694.jpg\"\/)
<\/p>\n
Bundan dolay\u0131 t\u00fcm d\u00fcnyada ve T\u00fcrkiye’de kalp yetersizli\u011fiyle m\u00fccadele i\u00e7in acil eylem planlar\u0131n\u0131n uygulanmas\u0131n\u0131n b\u00fcy\u00fck \u00f6nem ta\u015f\u0131d\u0131\u011f\u0131na i\u015faret eden De\u011fertekin, \u015funlar\u0131 kaydetti:<\/p>\n
“\u00c7\u00fcnk\u00fc t\u00fcm d\u00fcnyada \u00e7\u0131\u011f gibi b\u00fcy\u00fcyen bir hastal\u0131k olan kalp yetersizli\u011fi hem geli\u015fmi\u015f hem de geli\u015fen \u00fclkelerde giderek artmaktad\u0131r. TKD olarak biz de her y\u0131l Avrupa ile e\u015f zamanl\u0131 olarak \u00fclkemizde aktiviteler d\u00fczenleyerek bu hastal\u0131k ile ilgili hem fark\u0131ndal\u0131\u011f\u0131 art\u0131rmak hem de hasta, hasta yak\u0131nlar\u0131 ve sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131n\u0131 bu konuda bilgilendirmek i\u00e7in var g\u00fcc\u00fcm\u00fcz ile \u00e7al\u0131\u015f\u0131yoruz. Kalp yetersizli\u011fi geli\u015fimini engellemek, geli\u015fmi\u015fse ilerlemesini yava\u015flatmak ve ileri olgularda ya\u015fam s\u00fcresini uzat\u0131p ya\u015fam kalitesini y\u00fckseltmek ve bu hastal\u0131k ile m\u00fccadele etmek i\u00e7in \u00fczerimize d\u00fc\u015fen sorumlulu\u011fu yerine getirmeye devam edece\u011fiz.”<\/p>\n
![\"\"](\"https:\/\/www.aa.com.tr\/uploads\/userFiles\/96f91bbd-282f-4a24-a12c-1b1092cfeb3b\/009_2023%2F08_2023%2F27_Mayis%2F5%2F20230505_2_58537622_88647710.jpg\"\/)
<\/p>\n
“Bu etkinliklerin \u00e7ok fazla \u00f6nemi var”<\/h3>\n
Etkinli\u011fe kat\u0131lan oyuncu Apak da kalp yetersizli\u011finin \u00e7ok \u00f6nemli bir konu oldu\u011funa dikkati \u00e7ekerek, s\u00fcrekli egzersiz yapt\u0131\u011f\u0131n\u0131 ve d\u00fczg\u00fcn beslenmeye \u00f6zen g\u00f6sterdi\u011fini s\u00f6yledi.<\/p>\n
Apak, s\u00f6z konusu etkinli\u011fin toplumdaki bilinci art\u0131rmak a\u00e7\u0131s\u0131ndan faydal\u0131 oldu\u011funu belirterek, “Burada olmak \u00e7ok g\u00fczel. Bu tip etkinliklerin \u00e7ok fazla \u00f6nemi var. Bence geleneksel hale gelmeli, vatanda\u015f\u0131n daha fazla dahil olabilece\u011fi \u015fekilde bu i\u015f b\u00fcy\u00fcyerek devam etmeli.” ifadelerini kulland\u0131.<\/p>\n
![\"\"](\"https:\/\/www.aa.com.tr\/uploads\/userFiles\/96f91bbd-282f-4a24-a12c-1b1092cfeb3b\/009_2023%2F08_2023%2F27_Mayis%2F5%2F20230505_2_58537622_88647700.jpg\"\/)
<\/p>\n
“Kalp Yetersizli\u011fi Haftas\u0131”<\/h3>\n
Toplant\u0131da edinilen bilgilere g\u00f6re, hastaneye ba\u015fvuran her 2 hastadan 1’inin sonraki 5 y\u0131l i\u00e7inde ya\u015fam\u0131n\u0131 yitirdi\u011fi kalp yetersizli\u011fi, ayn\u0131 zamanda 65 ya\u015f \u00fcst\u00fc ki\u015filerde en s\u0131k hastaneye yat\u0131\u015f nedeni olarak saptan\u0131yor.<\/p>\n
![\"\"](\"https:\/\/www.aa.com.tr\/uploads\/userFiles\/96f91bbd-282f-4a24-a12c-1b1092cfeb3b\/009_2023%2F08_2023%2F27_Mayis%2F5%2F20230505_2_58537622_88647714.jpg\"\/)
<\/p>\n
Bu ger\u00e7e\u011fe dikkati \u00e7ekmek amac\u0131yla TKD her y\u0131l T\u00fcrkiye’de may\u0131s ay\u0131n\u0131n ilk haftas\u0131nda, “Kalp Yetersizli\u011fi Haftas\u0131” kapsam\u0131nda etkinlikler d\u00fczenliyor.<\/p>\n
Dernek bu etkinliklerde kalp yetersizli\u011finde fark\u0131ndal\u0131k olu\u015fturmak ad\u0131na hastal\u0131kla ilgili g\u00fcncel veri ve tedavi y\u00f6ntemlerini kamuoyu ile payla\u015f\u0131yor.<\/p>\n